Calton & Associates’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
Calton & Associates's BCAT Position: Q3 2026 in Review
Calton & Associates increased its BlackRock Capital Allocation Term Trust (BCAT) stake by 4.8% in Q3 2026, buying an estimated $8.51K and bringing the position to 11,993 shares worth $164K. The position accounts for 0.02% of the portfolio, ranked #481.
Calton & Associates first reported a position in BCAT in Q4 2021 and has held it in 19 quarters since. The position peaked at $422K in Q1 2024. 119 funds tracked by Wall St. Rank hold BCAT as of Q3 2026.
- Calton & Associates held 11,993 shares of BlackRock Capital Allocation Term Trust worth $164K as of Q3 2026.
- Calton & Associates bought 551 BlackRock Capital Allocation Term Trust shares in Q3 2026, an estimated $8.51K.
- BlackRock Capital Allocation Term Trust made up 0.02% of Calton & Associates's portfolio in Q3 2026, its #481 holding.
- Calton & Associates first reported a position in BlackRock Capital Allocation Term Trust in Q4 2021 and has held it in 19 quarters since.
- Calton & Associates's BlackRock Capital Allocation Term Trust position peaked at $422K in Q1 2024.
- 119 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q3 2026.
Based on Calton & Associates's 13F filing for Q3 2026, filed 13 Nov 2026.